Lithium carbonate
Lithium carbonate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Lithium carbonate; Generic name: LITHIUM CARBONATE; Manufacturer: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..
| Brand name | Lithium carbonate |
|---|---|
| Generic name | LITHIUM CARBONATE |
| Manufacturer | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Used for | INDICATIONS Lithium carbonate extended-release tablets are indicated in the treatment of manic episodes of Bipolar Disorder. Bipolar Disorder, Manic (DSM-IV) is equivalent to Manic Depressive illness, Manic, in the older DSM-II terminology. Lithium carbonate extended-release tablets are also indicated as a maintenance treatment for individuals with a diagnosis of Bipolar Disorder. Maintenance therapy reduces the frequency of manic episodes and diminishes the intensity of those episodes which may occur. Typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, elation, poor judgment, aggressiveness, and possibly hostility. |
| Dosage | DOSAGE AND ADMINISTRATION Acute Mania Optimal patient response can usually be established with 1,800 mg/day in the following dosages: 1 Can also be administered on 600 mg TID recommended dosing interval. ACUTE MANIA Morning Afternoon Nighttime Lithium Carbonate 3 tablets 3 tablets Extended-Release Tablets 1 (900 mg) (900 mg) Such doses will normally produce an effective serum lithium concentration ranging between 1.0 and 1.5 mEq/L. Dosage must be individualized according to serum concentrations |
| Warnings | WARNINGS Lithium Toxicity The toxic concentrations for lithium (≥1.5 mEq/L) are close to the therapeutic range (0.8 to 1.2 mEq/L). Some patients abnormally sensitive to lithium may exhibit toxic signs at serum concentrations that are considered within the therapeutic range (see BOXED WARNING and DOSAGE AND ADMINISTRATION ). Lithium may take up to 24 hours to distribute into brain tissue, so occurrence of acute toxicity symptoms may be delayed. Neurological signs of lithium toxicity range from mi |
| Active ingredient(s) | LITHIUM CARBONATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=074e3c3b-3a36-4c66-b0a7-e19f9aac8548 |